A 3-hour pan-fungal liquid biopsy. Detect, identify, and quantify invasive fungal pathogens directly from blood — with the speed of PCR and the breadth of sequencing.
Immunocompromised patients face life-threatening invasive fungal infections with mortality rates in some populations approaching 50% despite treatment. Current diagnostics force clinicians into difficult trade-offs.
Traditional methods yield results in days to weeks, with poor sensitivity for deep-seated infections.
Existing PCR tests are fast but cover only a handful of species, missing critical pathogens.
Next-generation sequencing offers breadth but requires specialized equipment, expertise, and days of turnaround.
MycoScan is a unique, powerful assay that detects microbial cell-free DNA in plasma. It combines speed, breadth, and accessibility in a single test.
Fast results with a simple process.
Detect all critical molds, yeasts, and dimorphic fungi with tailored resolution.
No specialized sequencing equipment required. Runs on general-purpose hardware already in labs.
Simpler and more affordable than NGS while maintaining comprehensive coverage.
Smart Keywords of Informative Primer Sequences
With underlying technology from Rice University, we design compact sets of informative probe-primer "keywords" to profile targeted cfDNA fragments. Each pathogen has a signature combination of keywords across many fragments, and dPCR allows fragments to be measured one molecule at a time.
Our reconstruction algorithm solves for the abundance of the pathogens — multiplexing the information, not the cost. No sequencing required.
Download WhitepaperCell-free DNA extracted from patient plasma
Informative probe-primer keywords on dPCR
Algorithmic fingerprints identify species & abundance
Actionable results in under 3 hours
MycoScan maps nearly any fungal pathogen into one of about 30 taxonomic groups, pairing comprehensive inclusivity with tailored taxonomic resolution where it matters. With an overall focus on deep-seated infections, the panel tilts toward molds while still resolving high-priority threats like C. auris.
Bold indicates taxa reported by MycoScan. Indentations indicate species we have demonstrated inclusivity on so far within the called groups.
Top institutions have been evaluating a beta version of MycoScan. Reach out to learn more about new collaboration opportunities in 2026.